In a recent study, Newsome et al
Supplements should only be used where a deficiency has been confirmed or is clinically suspected: Iron only if deficiency is confirmed on blood testing, as excess iron carries its own risks Zinc supports keratin production and follicle cycling, but should not be taken in high doses as excess zinc can cause copper deficiency [14] [15] Biotin widely marketed for hair health, but evidence for benefit in the absence of confirmed deficiency is limited
GLP-1/GIP, GLP-1/glucagon, and even triple agonists are the dominant focus, though the spectrum extends to other mechanisms as wellamylin, GIP antagonism, NK2 receptor agonism, and more, said DiMarchi Looking further ahead, DiMarchi sees potential for oral therapies, including oral peptides
Here's the three-party structure as the brand's materials describe it: The platform - RxSpan MD (RxSpan MD LLC)